Chronic intrarenal hyperinsulinemia does not cause hypertension

J. E. Hall, Michael W Brands, H. L. Mizelle, C. A. Gaillard, D. A. Hildebrandt

Research output: Contribution to journalArticle

63 Citations (Scopus)

Abstract

Hyperinsulinemia has been postulated to link obesity and hypertension via the antinatriuretic actions of insulin. The main goal of this study was to quantitate the importance of the direct intrarenal actions of insulin, independent of systemic effects, in altering blood pressure and renal function. This was accomplished by determining the responses to chronic intrarenal insulin infusion in uninephrectomized, chronically instrumented conscious dogs maintained on a 74 meq/day sodium intake. Insulin was infused at rates calculated to raise intrarenal, but not systemic, insulin to levels similar to those observed in obese hypertensive dogs. Intrarenal insulin infusion (0.6 mU·kg-1·min-1) for 7 days caused transient decreases in sodium excretion but no significant changes in potassium excretion. Mean arterial pressure did not change during 7 days of insulin infusion, averaging 93 ± 4 mmHg during control and 93 ± 3 mmHg during insulin infusion. Intrarenal insulin caused small increases in GFR but no significant changes in effective renal plasma flow or renal vascular resistance. These results demonstrate that insulin causes transient decreases in sodium excretion, but chronic intrarenal hyperinsulinemia does not elevate blood pressure in normal dogs. Additional factors other than the direct sodium-retaining effects of insulin may be important in raising blood pressure in obesity-associated hypertension.

Original languageEnglish (US)
JournalAmerican Journal of Physiology - Renal Fluid and Electrolyte Physiology
Volume260
Issue number5 29-5
StatePublished - Jan 1 1991
Externally publishedYes

Fingerprint

Hyperinsulinism
Insulin
Hypertension
Sodium
Dogs
Blood Pressure
Obesity
Effective Renal Plasma Flow
Kidney
Vascular Resistance
Potassium
Arterial Pressure

Keywords

  • Glomerular filtration rate
  • Kidney
  • Obesity
  • Sodium excretion

ASJC Scopus subject areas

  • Physiology

Cite this

Chronic intrarenal hyperinsulinemia does not cause hypertension. / Hall, J. E.; Brands, Michael W; Mizelle, H. L.; Gaillard, C. A.; Hildebrandt, D. A.

In: American Journal of Physiology - Renal Fluid and Electrolyte Physiology, Vol. 260, No. 5 29-5, 01.01.1991.

Research output: Contribution to journalArticle

Hall, J. E. ; Brands, Michael W ; Mizelle, H. L. ; Gaillard, C. A. ; Hildebrandt, D. A. / Chronic intrarenal hyperinsulinemia does not cause hypertension. In: American Journal of Physiology - Renal Fluid and Electrolyte Physiology. 1991 ; Vol. 260, No. 5 29-5.
@article{4b987121e50e459fbda6bf09cb2d4736,
title = "Chronic intrarenal hyperinsulinemia does not cause hypertension",
abstract = "Hyperinsulinemia has been postulated to link obesity and hypertension via the antinatriuretic actions of insulin. The main goal of this study was to quantitate the importance of the direct intrarenal actions of insulin, independent of systemic effects, in altering blood pressure and renal function. This was accomplished by determining the responses to chronic intrarenal insulin infusion in uninephrectomized, chronically instrumented conscious dogs maintained on a 74 meq/day sodium intake. Insulin was infused at rates calculated to raise intrarenal, but not systemic, insulin to levels similar to those observed in obese hypertensive dogs. Intrarenal insulin infusion (0.6 mU·kg-1·min-1) for 7 days caused transient decreases in sodium excretion but no significant changes in potassium excretion. Mean arterial pressure did not change during 7 days of insulin infusion, averaging 93 ± 4 mmHg during control and 93 ± 3 mmHg during insulin infusion. Intrarenal insulin caused small increases in GFR but no significant changes in effective renal plasma flow or renal vascular resistance. These results demonstrate that insulin causes transient decreases in sodium excretion, but chronic intrarenal hyperinsulinemia does not elevate blood pressure in normal dogs. Additional factors other than the direct sodium-retaining effects of insulin may be important in raising blood pressure in obesity-associated hypertension.",
keywords = "Glomerular filtration rate, Kidney, Obesity, Sodium excretion",
author = "Hall, {J. E.} and Brands, {Michael W} and Mizelle, {H. L.} and Gaillard, {C. A.} and Hildebrandt, {D. A.}",
year = "1991",
month = "1",
day = "1",
language = "English (US)",
volume = "260",
journal = "American Journal of Physiology - Heart and Circulatory Physiology",
issn = "0363-6135",
publisher = "American Physiological Society",
number = "5 29-5",

}

TY - JOUR

T1 - Chronic intrarenal hyperinsulinemia does not cause hypertension

AU - Hall, J. E.

AU - Brands, Michael W

AU - Mizelle, H. L.

AU - Gaillard, C. A.

AU - Hildebrandt, D. A.

PY - 1991/1/1

Y1 - 1991/1/1

N2 - Hyperinsulinemia has been postulated to link obesity and hypertension via the antinatriuretic actions of insulin. The main goal of this study was to quantitate the importance of the direct intrarenal actions of insulin, independent of systemic effects, in altering blood pressure and renal function. This was accomplished by determining the responses to chronic intrarenal insulin infusion in uninephrectomized, chronically instrumented conscious dogs maintained on a 74 meq/day sodium intake. Insulin was infused at rates calculated to raise intrarenal, but not systemic, insulin to levels similar to those observed in obese hypertensive dogs. Intrarenal insulin infusion (0.6 mU·kg-1·min-1) for 7 days caused transient decreases in sodium excretion but no significant changes in potassium excretion. Mean arterial pressure did not change during 7 days of insulin infusion, averaging 93 ± 4 mmHg during control and 93 ± 3 mmHg during insulin infusion. Intrarenal insulin caused small increases in GFR but no significant changes in effective renal plasma flow or renal vascular resistance. These results demonstrate that insulin causes transient decreases in sodium excretion, but chronic intrarenal hyperinsulinemia does not elevate blood pressure in normal dogs. Additional factors other than the direct sodium-retaining effects of insulin may be important in raising blood pressure in obesity-associated hypertension.

AB - Hyperinsulinemia has been postulated to link obesity and hypertension via the antinatriuretic actions of insulin. The main goal of this study was to quantitate the importance of the direct intrarenal actions of insulin, independent of systemic effects, in altering blood pressure and renal function. This was accomplished by determining the responses to chronic intrarenal insulin infusion in uninephrectomized, chronically instrumented conscious dogs maintained on a 74 meq/day sodium intake. Insulin was infused at rates calculated to raise intrarenal, but not systemic, insulin to levels similar to those observed in obese hypertensive dogs. Intrarenal insulin infusion (0.6 mU·kg-1·min-1) for 7 days caused transient decreases in sodium excretion but no significant changes in potassium excretion. Mean arterial pressure did not change during 7 days of insulin infusion, averaging 93 ± 4 mmHg during control and 93 ± 3 mmHg during insulin infusion. Intrarenal insulin caused small increases in GFR but no significant changes in effective renal plasma flow or renal vascular resistance. These results demonstrate that insulin causes transient decreases in sodium excretion, but chronic intrarenal hyperinsulinemia does not elevate blood pressure in normal dogs. Additional factors other than the direct sodium-retaining effects of insulin may be important in raising blood pressure in obesity-associated hypertension.

KW - Glomerular filtration rate

KW - Kidney

KW - Obesity

KW - Sodium excretion

UR - http://www.scopus.com/inward/record.url?scp=0025905564&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025905564&partnerID=8YFLogxK

M3 - Article

C2 - 2035653

AN - SCOPUS:0025905564

VL - 260

JO - American Journal of Physiology - Heart and Circulatory Physiology

JF - American Journal of Physiology - Heart and Circulatory Physiology

SN - 0363-6135

IS - 5 29-5

ER -